01 1Aurobindo Pharma Limited
02 1Emcure Pharmaceuticals Limited
03 1Enaltec Labs Pvt Ltd
04 1Harman Finochem Limited
05 1Harman finochem Limited
06 1Hubei Haosun Pharmaceutical Co., Ltd.
07 1Indoco Remedies Limited
08 1MEDISCA Inc.
09 1MSN Laboratories Private Limited
10 1Patheon Austria GmbH & CoKG
11 1Raks Pharma Pvt. Limited
01 1NEOSTIGMINE METHYLSULFATE
02 8Neostigmine Methylsulfate
03 1Neostigmine methyl sulfate
04 1Neostigmine methylsulfate
01 1China
02 8India
03 2U.S.A
NDC Package Code : 59651-243
Start Marketing Date : 2023-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-903
Start Marketing Date : 2020-02-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0153
Start Marketing Date : 2018-03-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66064-1020
Start Marketing Date : 2015-09-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14778-0707
Start Marketing Date : 2023-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14445-015
Start Marketing Date : 2016-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-1851
Start Marketing Date : 2017-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0022
Start Marketing Date : 2015-04-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45941-3053
Start Marketing Date : 2011-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-305
Start Marketing Date : 2018-06-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
60
PharmaCompass offers a list of Neostigmine Methylsulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neostigmine Methylsulfate manufacturer or Neostigmine Methylsulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neostigmine Methylsulfate manufacturer or Neostigmine Methylsulfate supplier.
PharmaCompass also assists you with knowing the Neostigmine Methylsulfate API Price utilized in the formulation of products. Neostigmine Methylsulfate API Price is not always fixed or binding as the Neostigmine Methylsulfate Price is obtained through a variety of data sources. The Neostigmine Methylsulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate, including repackagers and relabelers. The FDA regulates Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate supplier is an individual or a company that provides Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate active pharmaceutical ingredient (API) or Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate finished formulations upon request. The Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers may include Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API manufacturers, exporters, distributors and traders.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with NDC on PharmaCompass.
We have 10 companies offering Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate
Get in contact with the supplier of your choice:
